Cardinal Health Inc vs Carlyle Group Inc — how do they compare? Cardinal Health Inc trades at $240.13 (market cap $55.88B), while Carlyle Group Inc trades at $48.27 (market cap $17.23B). The key difference: Cardinal Health Inc is far larger — about 3.2× Carlyle Group Inc's market cap, and Carlyle Group Inc pays the higher dividend (2.9%). Which is the better fit depends on your goals.
| CAH | CG | |
|---|---|---|
Market Cap | $55.88B | $17.23B |
Sector | Health | Financials |
52-Week High | $240.26 | $69.35 |
52-Week Low | $146.04 | $40.52 |
Enterprise Value | $59.91B | — |
Dividend Yield | 0.86% | 2.9% |
Trailing returns across standard periods
Latest headlines on both assets
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →The Carlyle Group is one of the world's largest alternative-asset managers, with $376.4 billion in total assets under management, including $259.6 billion in fee-earning AUM, at the end of June 2022. The company has three core business segments: private equity, which includes private equity, real estate, infrastructure and natural resources funds (accounting for 41% of fee-earning AUM and 65% of base management fees during 2021), global credit (45% and 24%) and investment solutions (14% and 11%). The firm primarily serves institutional investors and high-net-worth individuals. Carlyle operates through 29 offices across five continents, serving close to 2,700 active carry fund investors from 95 countries.
Read more on CG →